Seizure Prophylaxis With Levetiracetam in Aneurysmal Subarachnoid Hemorrhage - Pilot Study

Withdrawn before enrolling · Phase 4

Conditions studied: Subarachnoid Hemorrhage, Seizures

In brief

The purpose of this study is to determine the feasibility of prospectively enrolling and randomizing patients with aneurysmal subarachnoid hemorrhage (aSAH) to receive levetiracetam or not to receive levetiracetam, and documenting in-hospital and follow-up clinical variables.

Key facts

Study ID

NCT01935908

Run by

Vanderbilt University Medical Center

People needed

0

Starts

2013-05-01

Expected to finish

2013-05-01

Last updated by the study team

2017-11-01

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 18 years of age
• ≤ 75 years of age
• Newly diagnosed aneurysmal subarachnoid hemorrhage

You may not qualify if…

• One or more antiepileptic medication is taken as a pre-admission medication
• Seizure occurrence in the field or in the emergency department, or anytime before consent could be obtained
• Inability to obtain informed consent from the patient, or from the patient's appropriate surrogate

Where it is running

• Vanderbilt University Medical Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.